Harvard Medical School

Ben Deverman, PhD | Senior Director of Vector Engineering at the Broad Institute of MIT and Harvard

Rewriting RNA: RSRT Funds Genetic Engineers in the AbuGoot Lab

copy_of_blog_banner_-_template

Using Cerebral Organoids to Develop MECP2-Activating Drugs for Rett Syndrome

hero-in-their-own-words-members-of-rsrts-newly-formed-translational-medicine-advisory-board-share-their-reasons-for-optimism

In their own words - members of RSRT’s newly formed Translational Medicine Advisory Board share their reasons for optimism

hero-the-power-of-three

The Power of Three

hero-breakthroughs-rna-editing

November 8, 2017

Breakthrough Discoveries for DNA & RNA Editing

hero-rsrt-awards-7-5-million-to-research-in-2016

RSRT Awards $7.5 Million to Research in 2016

hero-awaken-activate-mighty-x-chromosome

February 2, 2017

Awaken and Activate the Mighty X Chromosome

hero-rare-disease-drug-approval-sparks-controversy

December 14, 2016

Rare Disease Drug Approval Sparks Controversy

hero-new-trustee-apointed

New Trustee Appointed

hero-einstein-magazine-feature-on-rett-syndrome

November 24, 2015

Einstein Magazine Feature on Rett Syndrome

hero-rsrt-awards-400000-to-mark-zylka-for-long-genes-screening

RSRT Awards $400,000 to Mark Zylka for Long Genes Screening

Research from Harvard Points to Potential New Avenue for Treatment

February 6, 2015

RSRT Awards $5.8 Million For Research and Two Clinical Trials

January 14, 2015

MECP2 Consortium Update – Breaking Down the Walls

November 11, 2013

One Person Many Genomes

November 11, 2013

Cholesterol and neurological disorders

August 20, 2013

RSRT-funded Study Shows Gene Therapy Can Reverse Rett Symptoms in Mice

August 12, 2013

2013 Scientific Investments To Date

Roadmap to Cures

$40M